Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate Tablet
Product Images NDC 51407-948

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate (NDC 51407-948). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-948-30lb (Buprenorphine and Naloxone 2mg 0.5mg -rev 0426.jpg)

51407-948-30lb (Buprenorphine and Naloxone 2mg 0.5mg -rev 0426.jpg)
This text provides information on a medication called Buprenorphine and Naloxone Sublingual Tablets, USP. It contains 2 mg of buprenorphine HCI and 0.5 mg of naloxone HCl. The medication is used in cases of accidental ingestion by children and requires emergency medical care. A pharmacist's guidance is recommended for each patient. The typical dosage can be found in the package insert. The tablets should be stored at 20° to 25°C. The medication is marketed by G8MS, Incorporated, located in Camarillo, CA.*
FDA Label Image

51407-949-30lb (Buprenorphine and Naloxone 8mg 2mg)

51407-949-30lb (Buprenorphine and Naloxone 8mg 2mg)
This is a description of a medication, NDC 51407-949-30 Buprenorphine and Naloxone Sublingual Tablets, USP. Each tablet contains 8.64 mg of buprenorphine HCI, USP, equivalent to buprenorphine base, and 2.4 mg of naloxone HCI, USP, equivalent to 2mg of naloxone base. The usual dosage information can be found in the package insert for complete prescribing information. It is advised to keep this medication out of the reach of children and store it at 20° to 25°C (68° to 77°F). This medication is marketed by GSMS, Incorporated.*
FDA Label Image

Buprenorphine-chem-structure.jpg (Image 02)

FDA Label Image

Bupr-naloxone-ifu-mouth-image (Image 03)

FDA Label Image

Naloxone-chem-structure.jpg (Image 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.